abstract |
The present invention relates generally to the field of stabilization of gonadotropin formulations, in particular liquid formulations of gonadotropins. Stabilization is achieved by a specific combination of excipients, preferably arginine and methionine. In a preferred embodiment, the formulation does not contain a buffer. |